Measuring the accumulated hazards of smoking: global and regional estimates for 2000
Open accessAbstract
Objective:Current prevalence of smoking, even where data are available, is a poor proxy for cumulative hazards of smoking, which depend on several factors including the age at which smoking began, duration of smoking, number of cigarettes smoked per day, degree of inhalation, and cigarette characteristics such as tar and nicotine content or filter type. Methods:We extended the Peto-Lopez smoking impact ratio method to estimate accumulated hazards of smoking for different regions of the world. Lung cancer mortality data were obtained from the Global Burden of Disease mortality database. The American Cancer Society Cancer Prevention Study, phase II (CPS-II) with follow up for the years 1982 to 1988 was the reference population. For the global application of the method, never-smoker lung cancer mortality rates were chosen based on the estimated use of coal for household energy in each region. Results:Men in industrialised countries of Europe, North America, and the Western Pacific had the largest accumulated hazards of smoking. Young and middle age males in many regions of the developing world also had large smoking risks. The accumulated hazards of smoking for women were highest in North America followed by Europe. Conclusions:In the absence of detailed data on smoking prevalence and history, lung cancer mortality provides a robust indicator of the accumulated hazards of smoking. These hazards in developing countries are currently more concentrated among young and middle aged males.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous estimates of smoking-attributable burden in GBD relied on dichotomous exposures, despite well documented dose-response associations.
“Previous estimates of smoking-attributable burden in GBD relied on dichotomous exposures, despite well documented dose-response associations.”
From Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) · cites this paper as [24]
The introduction (section “S”; page not provided) says that earlier estimates underlying GBD 1990 tobacco mortality used the Peto–Lopez method to estimate accumulated smoking hazard indirectly, rather than relying on dichotomous exposure. It also says smoking risk depends on exposure history, supporting the dose-response premise but not the claim about the earlier GBD estimates. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredFor health outcomes modelled using daily prevalence in previous studies, risks among occasional smokers and former smokers were not included, and methods did not reflect dose-response associations between smoking intensity and risk of disease.
“For health outcomes modelled using daily prevalence, risks among occasional smokers and former smokers were not included, and methods did not reflect well described dose-response associations between smoking intensity and risk of disease.”
From Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) · cites this paper as [24]
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredFor health outcomes modelled using the Smoking Impact Ratio method, reliability was low in countries with scarce or poor quality data on lung cancer mortality and in countries with other important competing risks for lung cancer.
“For the health outcomes modelled using the Smoking Impact Ratio method, reliability was low in countries with either scare or poor quality data on lung cancer mortality and in countries with other important competing risks for lung cancer, such as air pollution.”
From Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) · cites this paper as [24]
The Population and mortality statistics section (page unavailable) says SIR reliability depends on lung-cancer mortality estimates and describes less reliable data and substantial uncertainty where registration is incomplete or absent. The Choice of never-smoker lung cancer mortality section (page unavailable) treats other lung-cancer risk factors, including urban air pollution, as sources of uncertainty. It does not say reliability was low in countries with those risks; it says ambient air pollution is not expected to greatly affect nonsmoker lung-cancer mortality. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492 · see citing works
Flagged first, then by citations
Research works printed but not linked: 28
- Doll R, Peto R, Wheatly K, et al. Mortality in relation to smoking: 40 years' observation on male British doctors. BMJ 1994;309:901-11.
- Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:1411-22.
- Nicolaides-Bouman A, Wald N, Forey B, et al, eds. International smoking statistics: a collection of historical data from 22 economically developed countries. London and Oxford: The Wolfson Institute of Preventive Medicine and Oxford University Press, 1993.
- Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries. Lancet 1992;339:1268-78.
- Yamaguchi N, Mochizuki-Kobayashi Y, Utsunomiya O. Quantitative relationship between cumulative cigarette smoking and lung cancer mortality in Japan. Int J Epidemiol 2000;29:963-8.
- Percy C, Muir C. The international comparability of cancer mortality data: results of an international death certificate study. Am J Epidemiol 1989;129:934-46.
- Percy C, Miller BA, Gloeckler Reis LA. Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann NY Acad Sci 1990;609:87-97.
- Bennett NG, Horiuchi S. Mortality estimation from registered deaths in less developed countries. Demography 1984;21:217-34.
- Hill K. Estimating census and death registration completeness. Asian and Pacific Population Forum 1981;1:8-13.
- Preston SH, Heuveline P, Guillot M. Demography: measuring and modelling population processes. Oxford: Blackwell, 2000.
- Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. In: Garfinkel L, Ochs O, Mushinkski M, eds. Selection, follow-up, and analysis in prospective studies: a workshop. NCI Monograph 67. Bethesda, Maryland: National Cancer Institute, 1985.
- Thun MJ, Day-Lally CA, Calle EE, et al. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 1995;85:1223-30.
- Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable mortality: confounding in the courtroom. JAMA 2000;284:706-12.
- Smith KR, Shuhua G, Kun H, et al. One hundred million improved cookstoves in China: how was it done? World Development 1993;21:941-61.
- Du YX, Cha Q, Chen XW, et al. An epidemiological study of risk factors for lung cancer in Guangzhou, China. Lung Cancer 1996;14:S9-37.
- Lan Q, Chapman RS, Schreinemachers DM, et al. Household stove improvement and risk of lung cancer in Xuanwei, China. J Ntl Cancer Inst 2002;94:826-35.
- Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000;78:1078-92.
- Doll R. Atmospheric pollution and lung cancer. Environ Health Perspect 1978;22:23-31.
- Jedrychowski W, Becher H, Wahrendorf J, et al. Case-control study of lung cancer with special reference to the effect of air pollution in Poland. J Epidemiol Community Health 1990;44:114-20.
- Vena JE. Air pollution as a risk factor in lung cancer. Am J Epidemiol 1982;116:42-56.
- Nyberg F, Gustavsson P, Jarup L, et al. Urban air pollution and lung cancer in Stockholm. Epidemiology 2000;11:487-95.
- Pope CA, III, Burnett RT, Thun MJ, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287:1132-41.
- Smith KR, Metha S, Feuz M. The global burden of disease from indoor air pollution: results from comparative risk assessment. Indoor Air 2002: Proceedings of the 9th International Conference on Indoor Air Quality and Climate. Monterey, California: Indoor Air, 2002;IV:10-19.
- Jha P, Ranson MK, Nguyen SN, et al. Estimates of global and regional smoking prevalence in 1995 by age and gender. Am J Public Health 2002;92:1002-6.
- Bronnum-Hansen H, Juel K. Estimating mortality due to cigarette smoking: two methods, same result. Epidemiology 2000;11:422-6.
- Valkonen T, van Poppel F. Smoking. The contribution of smoking to sex differences in life expectancy. Eur J Public Health 1997;7:302-10.
- Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 1997;315:980-8.
- Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997;315:973-80.
Cited by
Sorted by citations
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · see citing works
Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01169-7 · Cited by 1,759 · see citing works
Estimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247 · see citing works
Self-citationFarzadfar, F., Danaei, G., Namdaritabar, H., Rajaratnam, J. K., Marcus, J. R., Khosravi, A., Alikhani, S., Murray, C. J., & Ezzati, M. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-55 · Cited by 12 · see citing works
Self-citationOza, S., Thun, M. J., Henley, S. J., Lopez, A. D., & Ezzati, M. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.04.007 · Cited by 81 · see citing works
Self-citation
- Authors
- Ezzati, M., & Lopez, A. D.
- Affiliations
- Resources For The Future (US)
- ORCID
- Ezzati, M
- Venue
- Tobacco Control
- Publisher
- BMJ
- Published
- 2003-03
- Volume
- 12
- Issue
- 1
- Pages
- 79-85
- ISSN
- 0964-4563 (ISSN-L)
- 1468-3318
- PMC
- PMC1759096
- OpenAlex
- W2135351591
- Cited by
- 157
- References
- 1
- Citations by year
- 2025: 2 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 12 · 2014: 10 · 2013: 12 · 2012: 12
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Tobacco Control (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Resources for the Future
- World Health Organization
- National Institute on Aging (P01AG017625, 1-PO1-AG17625)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Keywords
- global burden of disease, regional estimates, young and middle-aged men, developing countries
- MeSH terms
- Adult, Aged, Developing Countries, Female, Humans, Lung Neoplasms, Male, Middle Aged, Risk Factors, Smoking, Global Health, Prevalence, Age Distribution, Sex Distribution, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review